Tagged with EALTH

India The USD 41 billion Indian pharma industry, the world’s third largest by volume and 13th largest by value, stands to grow by between 12 and 14 percent in the next three years, with exports predicted to grow by eight to 14 percent, according to a recent KPMG report.   The…

Global Dr Muhammad Ali Pate, Global Director for Health, Nutrition and Population at the World Bank as well as Director of the Global Financing Facility for Women, Children and Adolescents, reflects on the impact of the current COVID-19 pandemic on the work that the global institution has been doing to promote…

Belgium An overview of health and healthcare in Belgium with data on the country’s leading causes of death, healthcare expenditure and hospital infrastructure.   The top 10 causes of death in Belgium; ischemic heart disease stayed at number one between 2007 and 2017. Made with Visme Infographic Maker   Current levels of…

Canada Up-to-date data and infographics on the Canadian pharma market including an overview of market dynamics, pharmaceutical and biologics spending, production costs, and pricing changes.   Canada pharma data overview. Made with Visme Infographic Maker   Pharmaceutical spending as a percentage of GDP in Canada (international comparison). Made with Visme Infographic Maker  …

Europe A selection of data on the Nordic pharma markets (Denmark, Finland, Iceland, Norway, and Sweden), including market value, R&D spend, production, exports and imports, employment, generics penetration, and healthcare spending based on 2020 data from the EFPIA.    Sweden is the largest pharma market in the region, boasting a market…

Norway Norway, known more for its expertise in oil and gas and marine biology than in health innovation, is home to increasing numbers of innovative medical technology start-ups. Here are five of the most exciting such companies, as selected by Kathrine Myhre, founder and CEO of Oslo-based innovation cluster Norway Health…

Long Read Squirreled away in the lowlands of North West Europe and somewhat dwarfed by the mighty neighbouring pharmaceutical powerhouses of Germany and France, one could easily be forgiven for overlooking Belgium’s zesty life science ecosystem. At first glance, the numbers certainly appear more steady than thrilling: a EUR 5.4 billion domestic…

Belgium Carl Laurent, managing director and CEO of Siemens Healthineers BeLux, sits down with PharmaBoardroom to explain Siemens Healthineers’ footprint and impact in Belgium and Luxembourg, the importance of appreciating diagnostics as a means of cost reduction in healthcare, and the need to ensure access to the latest medtech innovations.  …

USA In recent years the US has seen an overall decease in cancer deaths thanks to innovative medicines and treatments. However, much work remains to be done in targeting and eliminating cancers. Below we highlight data for cancer deaths and cases in the US per male and female populations.     …

Belgium Christophe Van Damme, vice president and general manager of Perrigo Belgium and Luxembourg, shines a light on the transformation for Perrigo since its acquisition of Omega Pharma in 2015. Van Damme also explains Perrigo’s strategy for growth, the impact, opportunities, and challenges of the COVID-19 crisis, and how the self-care…

Opinion John G. Singer outlines why a focus on patients’ adherence to their medication is not necessarily useful in working to improve health outcomes and why innovation is more sorely needed in markets and strategies, not technologies and analytics.   “Monty Python and the Holy Grail,” which opened yesterday at the…

Morocco Sofia Lahlou, country manager for women’s and children’s health specialist Versalya in the Moroccan market, discusses the company’s formation, its therapeutic priorities, and the opportunities that exist for women in leadership in Morocco.   Today, we are the only laboratory in Morocco exclusively dedicated to women’s and children’s well-being, supporting…